Prostate Single Port & Laser Enucleation Comparison Trial
Randomized Controlled Trial Comparing Single Port Simple Prostatectomy and Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
University of Illinois at Chicago
116 participants
Jan 15, 2024
INTERVENTIONAL
Conditions
Summary
Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.
Eligibility
Inclusion Criteria1
- Patients diagnosed with symptomatic Benign Prostatic Hyperplasia (BPH) who fail conservative treatment with drug therapy are eligible for surgical intervention.
Exclusion Criteria1
- Adults unable to consent Prisoners Cognitive impaired adults Coagulopathy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Single port Robotic surgery will remove the whole prostate
Laser enucleation will remove chips of the prostate but keeping intact the prostate capsule.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06224218